Objective:-To examine the effect of intravaginal dehydroepiandrosterone on vagina and endometrium specially on symptoms and signs of vaginal atrophy and sexual dysfunction in postmenopausal women.Material and Method:-Study was conducted on 128 postmenopausal women between 40-75 year of age, presented with symptoms of vaginal atrophy and sexual dysfunction. Vaginal pH was determined, vaginal smear was examined for maturation index and maturation value, and endometrial biopsy was taken before and after intravaginal application of 0.5%DHEA ovules daily for 12 weeks.Results:-With DHEA, symptoms of sexual dysfunctions decreased significantly in 67% women (p<0.05), vaginal symptoms improved in 60% women (p<0.05).Vaginal pH was decreased by 1.1±0.06 unit (p<0.0001). Percentage of case with pH≤5 was increased to 79% from 34%, of parabasal cells decreased from 59.84±2.0 to 30.59±0.98 (p<0.0001) and of superficial cells increased by 8.66±0.18 (p<0.0001), maturation value increased by 20±0.63 (p<0.0001). Endometrial biopsy seen at the start of treatment remained unaffected by DHEA.Conclusion:-DHEA has many benefits of estrogen, with no side effects, and helps women with vaginal atrophy to stimulate the cellular growth of the vaginal wall and increase vaginal secretion, thus restoring the vagina to its youthful condition.Copy Right, IJAR, 2016,. All rights reserved.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.